Corebridge Financial Inc. lowered its position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 4.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 140,865 shares of the company’s stock after selling 6,650 shares during the quarter. Corebridge Financial Inc.’s holdings in HealthEquity were worth $13,516,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also added to or reduced their stakes in the company. Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity during the fourth quarter worth $26,000. Smartleaf Asset Management LLC raised its position in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in shares of HealthEquity in the 4th quarter valued at about $39,000. UMB Bank n.a. boosted its position in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after purchasing an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its stake in HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after purchasing an additional 445 shares during the period. Institutional investors own 99.55% of the company’s stock.
HealthEquity Stock Performance
NASDAQ HQY opened at $90.19 on Wednesday. The company has a fifty day moving average price of $104.40 and a 200-day moving average price of $95.94. The firm has a market cap of $7.80 billion, a price-to-earnings ratio of 82.74, a PEG ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on HQY
Insiders Place Their Bets
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is currently owned by insiders.
HealthEquity Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
- Five stocks we like better than HealthEquity
- What Are Dividends? Buy the Best Dividend Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Best Stocks Under $5.00
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- What is a buyback in stocks? A comprehensive guide for investors
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.